Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Extension Safety Trial in HIV Neuropathy
NCT01145417Phase 3Terminated
- Sponsor
- Viatris
- Start
- Jul 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in neuropathic pain, sponsored by Viatris. Primary endpoint: Number of Participants With Treatment Emergent Adverse Events and Serious Adverse Events. Started Jul 2010; status: terminated.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT01145417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01145417.